Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses

Annals of the New York Academy of Sciences

Volumn 905, Issue , 2000, Pages 242-259

  Xiao, Yijin ^a   Chen, Yonghong ^b,c   Kennedy, Alexander W ^a   Belinson, Jerome ^a   Xu, Yan ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c MAXYGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLSERINE; LYSOPHOSPHOLIPID;

CANCER DIAGNOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; MASS SPECTROMETRY; OVARY CANCER; THIN LAYER CHROMATOGRAPHY;

FALLOPIA;

EID: 0034015340     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06554.x     Document Type: Conference Paper

References (35)

1. 1. AMERICAN CANCER SOCIETY. 1999. Cancer Facts & Figures - 1999. Amer. Cancer Soc. Atlanta.
2. 2. BAST, R.C., JR., M. FEENEY, H. LAZARUS, L.M. NADLER, R.B. COLVIN & R.C. KNAPP. 1981. Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 1068: 1331-1337.
3. 3. BAST, R.C., JR., T.L. KLUG, E. ST. JOHN, E. JENISON, J.M. NILOFF, H. LAZARUS, R.S. BERKOWITZ, T. LEAVITT, C.T. GRIFFITHS, L. PARKER, V.R. ZURAWSKI, JR. & R.C. KNAPP. 1983. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309: 883-887.
4. 4. JACOBS, I. & R.C. BAST, JR. 1989. The CA 125 tumor-associated antigen: a review of the literature. Hum. Reprod. 4: 1-12.
5. 5. WOOLAS, R.P., F.J. XU, I.J. JACOBS, Y.H. YU, L. DALY, A. BERCHUCK, J.T. SOPER, D.L. CLARKE-PEARSON, D.H. ORAM & R.C. BAST, JR. 1993. Elevation of multiple serum markers in patients with stage I ovarian cancer. J. Natl. Cancer Inst. 85: 1748-1751.
6. 6. TAYLOR, K.J.W. & P.E. SCHWARTZ. 1994. Screening for early ovarian cancer. Radiology 192: 1-10.
7. 7. SCHWARTZ, P.E. & K.J. TAYLOR. 1995. Is early detection of ovarian cancer possible? Ann. Med. 27: 519-528.
8. 8. BEREK, J.S. & R.C. BAST, JR. 1995. Ovarian cancer screening. Cancer 76: 2092-2095.
9. 9. MACKEY, S.E. & W.T. CREASMAN. 1995. Ovarian cancer screening J. Clin. Oncol. 13: 783-793.
10. 10. CHEN, L-M. & E.Y. KARLAN. 1998. Early detection and risk reduction for familial gynecologic cancers. Clin. Obstet. Gynecol. 41: 200-214.
11. 11. TAYLOR, K.J.W. & P.E. SCHWARTZ. 1994. Screening for early ovarian cancer. Radiology 192: 1-10.
12. 12. XU, Y., D.C. GAUDETTE, J. BOYNTON, A. FRANKEL, X-J. FANG, A. SHARMA, J. HURTEAU, G. CASEY, A.E. GOODBODY, A. MELLORS, B.J. HOLUB & G. MILLS. 1995. Characterization of an ovarian cancer activating factor (OCAF) in ascites from ovarian cancer patients. Clin. Cancer Res. 1: 1223-1232.
13. 13. XU, Y., X-J. FANG, G. CASEY & G.B. MILLS. 1995. Lysophospholipids activate ovarian and breast cancer cells. Biochem. J. 309: 933-940.
14. 14. XU, Y., Z. SHEN, D.W. WIPER, M. WU, R.E. MORTON, P. ELSON, A.W. KENNEDY, J. BELINSON, M. MARKMAN & G. CASEY. 1998. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 280: 719-723.
15. 15. WATSON, S.P., R.T. MCCONNELL & E.G. LAPETINA. 1985. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action: evidence against a second messenger role of lysophosphatidic acid. Biochem. J. 232: 61-66.
16. 16. TIGYI, G., A. HENSCHEN & R. MILEDI. 1991. A factor that activates oscillatory chloride currents in Xenopus oocytes copurifies with a subfraction of serum albumin. J. Biol. Chem. 266: 20602-20609.
17. 17. TIGYI, G. & R. MILEDI. 1992. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J. Biol. Chem. 267: 21360-21367.
18. 18. EICHHOLTZ, T., K. JALINK, I. FAHRENFORT & W.H. MOOLENAAR. 1993. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291: 677-680.
19. 19. TOKUMURA, A., M. IIMORI, Y. NISHIOKA, M. KITAHARA, M. SAKASHITA & S. TANAKA. 1994. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am. J. Physiol. 267: C204-C210.
20. 20. WEINTRAUB, S.T., R.N. PINCKARD & M. HAIL. 1991. Electrospray ionization for analysis of platelet-activating factor. Rapid Commun. Mass Spectrom. 5: 309-311.
21. 21. KERWIN, J.L., A.R. TUININGA & L.H. ERICSSON. 1994. Identification of molecular species of glycerophospholipids and sphingomyelin using electrospray mass spectrometry. J. Lipid Res. 35: 1102-1114.
22. 22. HAN, X. & R.W. GROSS. 1994. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc. Natl. Acad. Sci. U.S.A. 91: 10635-10639.
23. 23. KERWIN, J.L., A.R. TUININGA, A.M. WIENS, J.C. WANG, J.J. TORVIK, M.L. CONRATH & J.K. MACKICHAN. 1995. Isoprenoid-mediated changes in the glycerophospholipid molecular species of the sterol auxotrophic fungus Lagenidium giganteum. Microbiology 141: 399-410.
24. 24. KERWIN, J.L., A.M. WIENS & L.H. ERICSSON. 1996. Identification of fatty acids by electrospray mass spectrometry and tandem mass spectrometry. J. Mass Spectrom. 31: 184-192.
25. 25. HAN, X., R.A. GUBITOSI-KLUG, B.J. COLLINS & R.W. GROSS. 1996. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. Biochemistry 35: 5822-5832.
26. 26. CHILTON, F.H., F.J. AVERILL, W.C. HUBBARD, A.N. FONTEH, M. TRIGGIANI & M.C. LIU. 1996. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 183: 2235-2245.
27. 27. HOISCHEN, C., W. IHN, K. GURA & J. GUMPERT. 1997. Structural characterization of molecular phospholipid species in cytoplasmic membranes of the cell wall-less Streptomyces hygroscopicus L form by use of electrospray ionization coupled with collision-induced dissociation mass spectrometry. J. Bacteriol. 179: 3437-3442.
28. 28. WATSON, A.D., N. LEITINGER, M. NAVAB, K.F. FAULL, S. HORKKO, J.L. WITZTUM, W. PALINSKI, D. SCHWENKE, R.G. SALOMON, W. SHA, G. SUBBANAGOUNDER, A.M. FOGELMAN & J.A. BERLINER. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272: 13597-13607.
29. 29. WOLF, R., K. RAITH & R. NEUBERT. 1997. Separation and quantitation of glycolipids penetration modifiers in human skin using high-performance liquid chromatography-mass spectrometry with electrospray ionization. J. Chromatogr. A766: 71-75.
30. 30. MANO, N., Y. ODA, K. YAMADA, N. ASAKAWA & K. KATAYAMA. 1997. Simultaneous quantitative determination method for sphingolipid metabolites by liquid chromatography/ionspray ionization tandem mass spectrometry. Anal. Biochem. 244: 291-300.
31. 31. RAMANADHAM, S., F.F. HSU, A. BOHRER, W. NOWATZKE, Z. MA & J. TURK. 1998. Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: comparison to other tissues and implications for membrane fusion in insulin exocytosis. Biochemistry 37: 4553-4567.
32. 32. KARLSSON, A.A., P. MICHELSEN & G. ODHAM. 1998. Molecular species of sphingomyelin: determination by high-performance liquid chromatography/mass spectrometry with electrospray and high-performance liquid chromatography/tandem mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spectrom. 33: 1192-1198.
33. 33. HSU, F.F., A. BOHRER & J. TURK. 1998. Formation of lithiated adducts of glycerophosphocholine lipids facilitates their identification by electrospray ionization tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 9: 516-526.
34. 34. WORLD HEALTH ORGANIZATION. 1979. WHO Handbook for Reporting Results of Cancer Treatment. World Health Organization. Geneva.
35. 35. OKITA, M., D.C. GAUDETTE, G.B. MILLS & B.J. HOLUB. 1997. Elevated levels and altered fatty acid composition of plasma lysophosphatidyicholine (lysoPC) in ovarian cancer patients. Int. J. Cancer 71: 31-34.